APA (7th ed.) Citation

Prakoso, E., Strasser, S. I., Koorey, D. J., Verran, D., & McCaughan, G. W. (2006). Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors. Clinical Transplantation, 20(3), 369. https://doi.org/10.1111/j.1399-0012.2006.00495.x

Chicago Style (17th ed.) Citation

Prakoso, Emilia, Simone I. Strasser, David J. Koorey, Deborah Verran, and Geoffrey W. McCaughan. "Long-term Lamivudine Monotherapy Prevents Development of Hepatitis B Virus Infection in Hepatitis B Surface-antigen Negative Liver Transplant Recipients from Hepatitis B Core-antibody-positive Donors." Clinical Transplantation 20, no. 3 (2006): 369. https://doi.org/10.1111/j.1399-0012.2006.00495.x.

MLA (9th ed.) Citation

Prakoso, Emilia, et al. "Long-term Lamivudine Monotherapy Prevents Development of Hepatitis B Virus Infection in Hepatitis B Surface-antigen Negative Liver Transplant Recipients from Hepatitis B Core-antibody-positive Donors." Clinical Transplantation, vol. 20, no. 3, 2006, p. 369, https://doi.org/10.1111/j.1399-0012.2006.00495.x.